When Finasteride Side Effects Appear
Sexual side effects from finasteride typically emerge during the first year of treatment, with the highest incidence occurring in Year 1, followed by a decrease in subsequent years, though some effects may persist or even appear after discontinuation.
Timing of Side Effects During Treatment
Year 1: Peak Incidence
According to FDA labeling data from the 4-year placebo-controlled study, sexual side effects are most frequent during the first year of treatment 1:
- Impotence: 8.1% (vs 3.7% placebo)
- Decreased libido: 6.4% (vs 3.4% placebo)
- Decreased ejaculate volume: 3.7% (vs 0.8% placebo)
- Gynecomastia: 0.5% (vs 0.1% placebo)
Years 2-4: Reduced Incidence
The incidence of sexual dysfunction decreases significantly after the first year 2, 1. In Years 2-4 combined:
- Impotence: 5.1% (equal to placebo at 5.1%)
- Decreased libido: 2.6% (equal to placebo at 2.6%)
- Decreased ejaculate volume: 1.5% (vs 0.5% placebo)
The guideline evidence notes that "sexual dysfunction associated with finasteride decreased over time, although it remained statistically significant" 2.
Important Clinical Context
Magnitude of Effects
The actual magnitude of sexual dysfunction is relatively modest. On a 0-100 scale, finasteride produced a mean difference of only 3.21 points compared to 1.26 points for each year of aging 2. This suggests the effect is smaller than natural age-related variability.
Discontinuation Rates
Only 3.7% of patients discontinued finasteride due to sexual side effects over 4 years, compared to 2.1% on placebo 1. Overall discontinuation rates were similar between finasteride and placebo (approximately 15% each) 2.
Post-Discontinuation Effects: A Critical Caveat
A concerning subset of patients report persistent sexual and non-sexual side effects that continue after stopping finasteride, termed "post-finasteride syndrome" (PFS) 3, 4, 5. In one study of 71 men:
- Mean duration of finasteride use: 28 months
- Mean duration of persistent symptoms after discontinuation: 40 months 5
- 94% reported persistent low libido
- 92% reported persistent erectile dysfunction
Recent animal studies demonstrate that withdrawal from finasteride may actually induce new symptoms, including anxiety-like behavior and hyperactivity that were not present during treatment 6.
Post-Discontinuation Timeline
The evidence suggests a dichotomy between immediate and delayed effects: while effects during treatment may be mild, significant behavioral and sexual alterations can emerge specifically at withdrawal 6. This means patients should be monitored not only during treatment but also following discontinuation.
Practical Monitoring Algorithm
For patients starting finasteride:
Baseline assessment (before starting): Document sexual function, mood, and any pre-existing symptoms
Month 1-3: Monitor for early onset of sexual side effects (peak risk period)
Month 6-12: Continue monitoring as Year 1 represents highest incidence period
Years 2+: Side effects typically decrease but remain above placebo levels for ejaculate volume
Post-discontinuation: Critical monitoring period - follow patients for at least 3-6 months after stopping, as new or persistent symptoms may emerge during withdrawal
Key Clinical Pitfalls
- Don't assume all side effects resolve with discontinuation: Persistent effects are documented and may last years 3, 4, 5
- Nocebo effect is real: One study found 43.6% reported sexual side effects when counseled about them vs 15.3% when not informed 7, though this doesn't negate genuine persistent effects
- Withdrawal may trigger new symptoms: Animal data suggests discontinuation itself may induce anxiety and behavioral changes 6
Counsel patients that while most side effects occur in Year 1 and may decrease over time, a subset of patients experience persistent symptoms lasting months to years after stopping the medication.